Cargando…
Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome
BACKGROUND AND PURPOSE: Antiganglioside antibodies are known to play a pathogenic role in Guillain-Barré syndrome (GBS). Either an immunoglobulin (Ig)G- or IgM-type anti-GM2 antibody is detected in rare cases in GBS patients. However, the specific pathogenic role of these antibodies in GBS has not b...
Autores principales: | Kim, Jong Kuk, Kim, Yoo Hwan, Yoon, Byeol-A, Cho, Joong-Yang, Oh, Sun-Young, Shin, Ha Young, Kim, Ji Soo, Park, Kee Hong, Kim, Sun Young, Suh, Bum Chun, Seok, Hung Youl, Yoo, Jin Hyuk, Bae, Jong Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031993/ https://www.ncbi.nlm.nih.gov/pubmed/29971981 http://dx.doi.org/10.3988/jcn.2018.14.3.401 |
Ejemplares similares
-
The Ganglioside GM3 Is Associated with Cisplatin-Induced Apoptosis in Human Colon Cancer Cells
por: Chung, Tae-Wook, et al.
Publicado: (2014) -
The Impacts of Influenza Infection and Vaccination on Exacerbation of Myasthenia Gravis
por: Seok, Hung Youl, et al.
Publicado: (2017) -
Bilateral Facial Weakness with Distal Paresthesia Following COVID-19 Vaccination: A Scoping Review for an Atypical Variant of Guillain–Barré Syndrome
por: Kim, Yoo-Hwan, et al.
Publicado: (2022) -
Ganglioside GM3 Up-Regulate Chondrogenic Differentiation by Transform Growth Factor Receptors
por: Ryu, Jae-Sung, et al.
Publicado: (2020) -
Prevalence of Anti-Ganglioside Antibodies and Their Clinical Correlates with Guillain-Barré Syndrome in Korea: A Nationwide Multicenter Study
por: Kim, Jong Kuk, et al.
Publicado: (2014)